Microalbuminuria and uric acid in healthy subjects

Journal of Nephrology

Volumn 19, Issue 4, 2006, Pages 458-464

  Bellomo, Gianni ^a   Berardi, Pietro ^a   Saronio, Paolo ^a   Verdura, Claudio ^a   Esposito, Antonella ^a   Laureti, Alessandro ^a   Venanzi, Sandro ^a   Timio, Francesca ^a   Timio, Mario ^a  

^a MOLINETTE HOSPITAL   (Italy)

Author keywords

Blood pressure; Microalbuminuria; Uric acid

Indexed keywords

ALBUMIN; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; URIC ACID;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION FUNCTION; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MULTIPLE REGRESSION; PREDICTION; PREVALENCE; SEX RATIO; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL; ALBUMINURIA; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; MIDDLE AGED; URINE;

ADULT; AGED; ALBUMINURIA; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CREATININE; FEMALE; HUMANS; MALE; MIDDLE AGED; URIC ACID;

EID: 37849188418     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Warram JH, Gearin G, Laffel L, Krolewski AS. Effect of duration of type 1 diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol 1996; 7: 930-7.
2. Mogensen CE. Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes. Intern Med 2003; 254: 45-66.
3. Karalliedde J, Viberti G. Microalbuminuria and cardiovascular risk. Am J Hypertens 2004; 17: 986-93.
4. Torres Rosa T, Palatini P. Clinical value of microalbuminuria in hypertension. J Hypertens 2000; 18: 645-54.
5. Pontremoli R, Leoncini G, Ravera M, Viazzi S, Vettoretti S, Ratto E, Parodi D, Tomolillo C, Deferrari G. Microalbuminuria, cardiovascular and renal risk in primary hypertension. J Am Soc Nephrol 2002; 13 (Suppl): S169-72.
6. Lindeman RD, Romero L, Liang HC, Hundley R, Baumgartner R, Koehler K, Garry P. Prevalence of proteinuria/microalbuminuria in an elderly urban, biethnic community. Geriatr Nephrol Urol 1998; 8: 123-30.
7. Tomura S, Kawada K, Saito K, Lin YL, Endou K, Hirano C, Yanagi H, Tsuchiya S, Shiba K. Prevalence of microalbuminuria and relationship to the risk of cardiovascular disease in the Japanese population. Am J Nephrol 1999; 19: 13-20.
8. Gerstein HC, Mann JF, Yi Q Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S. HOPE Study Investigators. Albuminuria and risk of cardiovascular events, death and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 25: 421-6.
9. Hillege HL, Fidler V, Diercks GFH, Van Gilst WH, de Zeeuw D, van Veldhuisen DJ, Gans RO, Janssen WM, Grobbee DE, de Jong PE; for the Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106: 1777-82.
10. Jones CA, Francis ME, Eberhardt MS, Chavers B, Coresh J, Engelgau M, Kusek JW, Byrd-Holt D, Narayan KMV, Herman WH, Jones CP, Salive M, Agodoa LY Microalbuminuria in the US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2002; 39: 445-59.
11. Barzilay JI, Peterson D, Cushman M, Heckbert SR, Cao JJ, Blaum C, Tracy RP, Klein R, Herrington DM. The relationship of cardiovascular risk factors to microalbuminuria in older adults with and without diabetes mellitus or hypertension: the Cardiovascular Health Study. Am J Kidney Dis 2004; 44: 25-34.
12. Yuyun MF, Khaw KT, Luben R, Welch A, Bingham S, Day NE, Wareham NJ. Microalbuminuria, cardiovascular risk factors and cardiovascular morbidity in a British population: The EPIC-Norfolk population-based study. Eur J Cardiovasc Prev Rehabil 2004; 11: 207-13.
13. Klausen K, Borch-Jonsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H, Appleyard M, Skov Jensen J. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension and diabetes. Circulation 2004; 110: 32-5.
14. Nieto FJ, Iribarren C, Gross MD, Comstock GW, Cutler RG. Uric acid and serum antioxidant capacity: A reaction to atherosclerosis? Atherosclerosis 2000; 148: 131-9.
15. Tseng CH. Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan. Kidney Int 2005; 68: 796-801.
16. Johnson RJ, Segal MS, Srinivas T, Ejaz A, Mu W, Roncal C, Sànchez-Losada LG, Gersch M, Rodriguez-Iturbe B, Kang DH, Herrera Acosta J. Essential hypertension, progressiva renal disease, and uric acid: A pathogenetic link? J Am Soc Nephrol 2005; 16: 1909-19.
17. Viazzi F, Parodi D, Leoncini G, Parodi A, Falqui V, Ratto E, Vettoretti S, Bezante GP, Del Sette M, Deferrari G, Pontremoli R. Serum uric acid and target organ damage in primary hypertension. Hypertension 2005; 45: 991-6.
18. Short RA, Johnson RJ, Tuttle KR. Uric acid, microalbuminuria and cardiovascular events in high-fisk patients. Am J Nephrol 2005; 25: 36-44.
19. Wheeler JG, Juzwishin KD, Eiriksdottir G, Gudnason V, Danesh J. Serum uric acid and coronary heart disease in 9458 incident cases and 155084 controls: Prospective study and meta-analysis. PLoS Med 2005; 2: 236-43.
20. Reyes AJ. Cardiovascular drugs and serum uric acid. Cardiovasc Drugs Ther 2005; 17: 397-414.
21. Reyes AJ. The increase in serum uric acid caused by diuretics might be beneficial in heart failure. Eur J Heart Fail 2005; 7: 461-7.
22. Iseki F, Ikemiyia Y, Inoue T, Iseki C, Kinjo K, Takishita S. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 2004; 44: 642-50.
23. Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, Kivlighn S, Johnson R. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001; 38: 1101-6.
24. Sanchez-Losada LG, Tapia E, Avila-Casado C, Soto V, Franco M, Santamaria J, Nakagawa T, Rodriguez-Iturbe B, Johnson RJ, Herrera Acosta J. Mild hyperuricemia induces glomerular hypertension in normal rats. AmJ Physiol Renal Physiol 2002; 283: F1105-10.
25. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-53.
26. Grundy S. Primary prevention of coronary heart disease: Integrating risk assessment with intervention, Circulation 1999; 100: 988-98.
27. Gansevoort RT, Verhave JC, Hillege HL, Burgerhof JG, Bakker SJ, de Zeeuw D, de Jong PE; for the PREVEND Study Group. The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population. Kidney Int 2005; (Suppl 95): S28-35.
28. Wang TJ, Evans JC, Meigs JB, Rifai N, Fox CS, D'Agostino RB, Levy D, Vasan RS. Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation 2005; 111: 1370-6.
29. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, Block ER, Prabhakar S, Johnson RJ. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005; 67: 1739-42.
30. Mercuro G, Vitale C, Cerquetani E, Zoncu S, Deidda M, Fini M, Rosano GM. Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol 2004; 94: 932-5.
31. Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, Wamsley A, Sheikh-Haxnad D, Lan HY, Feng L, Johnson RJ. Uric acid stimulates MCP-1 production in vascular smooth cells via MAPK and COX-2. Hypertension 2003; 41: 1287-93.
32. Johnson RJ, Kivlighn SD, Kim YG, Suga S, Fogo A. Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease. Am J Kidney Dis 1999; 33: 225-34.
33. Ohno I, Hosoya T, Gomi H, Ichida K, Okabe H, Hikita M. Serum uric acid and renal prognosis in IgA nephropathy. Nephron 2001; 87: 333-9.